Madridge Journal of Internal and Emergency Medicine

ISSN: 2638-1621

International Translational and Regenerative Medicine Conference
April 25-27, 2018 | Rome, Italy

Protecting and Transferring Inventions Developed by the Government and Government-Funded Academic Research

Ami Gadhia

National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), U.S. Department of Health and Human Services (HHS), USA

DOI: 10.18689/2638-1621.a1.004

Download PDF

U.S. Government research and Government-funded academic research is vital to innovation of pharmaceuticals and medical devices. This research may complicate how rights to inventions can be used. The conflicting demands of research and the patent law can sometimes put scientific work at odds with effective patent protection. We will discuss issues faced by government agencies, academic institutions and potential industry partners that are considering engaging in technology transfer. We will discuss how such funding affects the right to exploit and to license IP. We will look at what government agencies and academic institutions could do to effectively secure IP rights that not only serve the public good but that are also attractive to investors, therefore increasing the likelihood of commercialization success.

Dr. Ami Gadhia is a Technology Transfer and Patenting Specialist at the National Center for Advancing Translational Sciences (NCATS), a Center within the National Institutes of Health (NIH), U.S. Department of Health and Human Services (HHS). Dr. Ami negotiates agreements that allow for collaboration and translation of research. Prior to NCATS, she worked at Johns Hopkins since 2007, where she lead a team of licensing professionals and managed her own docket of technologies, as a portfolio director for technology licensing. Dr. Ami is a certified licensing professional, is registered to practice before the U.S. Patent and Trademark Office, and is a member of the State Bar of Georgia.